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Abstract
Genome-wide experiments to map the DNA-binding locations of transcription-associated
factors (TFs) have shown that the number of genes bound by a TF far exceeds the num-
ber of possible direct target genes. Distinguishing functional from non-functional binding is
therefore a major challenge in the study of transcriptional regulation. We hypothesized that
functional targets can be discovered by correlating binding and expression profiles across mul-
tiple experimental conditions. To test this hypothesis, we obtained ChIP-seq and RNA-seq
data from matching cell types from the human ENCODE resource, considered promoter-
proximal and distal cumulative regulatory models to map binding sites to genes, and used a
combination of linear and non-linear measures to correlate binding and expression data. We
found that a high degree of correlation between a gene’s TF-binding and expression profiles
was significantly more predictive of the gene being differentially expressed upon knockdown
of that TF, compared to using binding sites in the cell type of interest only. Remarkably, TF
targets predicted from correlation across a compendium of cell types were also predictive of
functional targets in other cell types. Finally, correlation across a time course of ChIP-seq
and RNA-seq experiments was also predictive of functional TF targets in that tissue.
Background
Transcriptional regulation by DNA-binding transcription-associated factors and chromatin mod-
ifiers (here collectively abbreviated as “TFs”) is a fundamental process determining all aspects
of cell behaviour, and TFs are known to be essential for a wide range of important cellular and
organismal phenotypes. Using ChIP-sequencing technology[1], the ENCODE and modENCODE
consortia have generated detailed maps of the genomic locations where TFs bind in diverse hu-
man cell types [2] and in important model organisms [3, 4, 5]. Invariably, these experiments have
demonstrated that TFs bind throughout the genome over a quantitative continuum of occupancy
levels [6] and that the number of binding events can significantly exceed the number of known
or possible direct target genes [7]. Hence, predicting when the binding of a TF in a gene locus
will lead to a biologically significant change in the rate of transcription of the neighbouring gene
(“functional DNA binding”, see the glossary of terms by Biggin [6]) is a challenging and largely
unsolved problem.
Several studies have recently used ChIP-sequencing data of TFs and/or histone modifications
to predict absolute expression levels in a particular cell type [8, 9, 10, 11]. While these studies
show that a large proportion of the variation in expression levels across genes can be explained
by the presence or absence of TF-binding sites for particular combinations of TFs [8, 9], this
approach is ill-suited to predict functional TF targets, i.e. to predict differential gene expression
in a particular cell type upon perturbation of the TF. Indeed, a recent large-scale study where 59
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TFs where knocked down in a human lymphoblastoid cell line (GM12878) concluded that only
a small subset of genes bound by a factor within 10kb of their transcription start site (TSS)
were differentially expressed following knockdown of that factor [12]. However, Cheng et al. [9]
also showed that differential TF binding between two cell types correlates with differential gene
expression between those two cell types, suggesting that functional TF target genes can possibly
be predicted through the “guilt-by-association” principle by correlating TF-occupancy and gene
expression levels across multiple cell types.
In other applications of genomics, function is often predicted in this manner. Genes with similar
expression profiles [13, 14], genetic interaction profiles [15] or protein interaction partners [16]
often share the same molecular function. Likewise, putative DNA-regulatory motifs are identified
from their shared occurrence in the upstream regulatory sequences of co-expressed genes [17],
networks of TF-regulatory interactions are inferred by associating TF activity profiles to candidate
target expression levels [18, 19, 20], and long-range DNA contact interactions between regulatory
elements and putative target genes can be predicted by correlating open chromatin (measured by
sequencing DNase I hypersensitive sites [21]) and gene expression levels across multiple cell types
[22, 23, 24, 25, 26].
To test the hypothesis that the guilt-by-association principle applies to the discovery of func-
tional TF target genes, we used ChIP- and RNA-sequencing data across multiple cell types from the
human ENCODE resource [2]. We considered several cumulative regulatory models to map ChIP-
peaks to genes, ranging from proximal binding to incorporating distal events: 1kb/5kb/10kb/50kb
around the TSS, the nearest TSS, and 1kb/5kb around the TSS and in the gene body. This is
consistent with the emerging view that TF-binding sites act redundantly to promote robustness
against genetic and environmental perturbations, and that they may regulate their target genes
in a cumulative manner [27]. Furthermore, since there exists no gold standard data of functional
DNA-binding events (in the sense defined above), we used the knockdown data of Cusanovich et
al. [12] as a proxy measurement. Five of the knocked down factors had ChIP-seq binding maps
available in at least ten cell types in the human ENCODE data, with matching RNA-seq gene
expression data, and were considered in this study. Using three different correlation measures,
individually and in combination, we found that the correlation between variation in cumulative
binding around the TSS of a gene and variation in expression levels of that gene was a better pre-
dictor of functional effects than the presence of multiple binding events in the cell type where the
TF knockdown was performed. Remarkably, these results were confirmed when using correlation
across a time course of ChIP-seq and RNA-seq experiments during mouse circadian rhythm [28].
Methods
Preparation of data
The binding events (peaks) for eight transcription-associated factors (CEBPB, EP300, EZH2,
MYC, RAD21, REST, TAF1 and YY1) with binding profiles in ten or more cell types were down-
loaded from the ENCODE resource [2]. Peaks were mapped to transcription start sites (GEN-
CODE v12) using seven different models (1kb/5kb/10kb/50kb around the TSS, the nearest TSS,
and 1kb/5kb around the TSS and in the gene body). To calculate the peak height at each peak, we
downloaded the corresponding mapped read files (BED files) for each sample from the ENCODE
resource. We then calculated the coverage using BEDTOOLs and normalized coverage count was
used as an estimate for peak height. The RPKM values of RNA sequencing data (GENCODE
v12) for the corresponding cell lines were also downloaded from the ENCODE resource. They
were then quantile normalised using R to be comparable across samples. ENCODE binding and
expression profiles were available for 24,392 genes. The global expression change (in the form of
differential expression P -values) upon deletion of five of the eight factors (EP300, EZH2, RAD21,
TAF1 and YY1) in a lymphoblastoid cell line (GM12878) was available for 8,872 genes (also called
the “reference genes” below) [12]. Differentially expressed genes upon deletion of CEBPB were
obtained directly from the Gene Expression Omnibus using the GEO2R tool (accession number:
2
GSE54975). Differentially expressed genes upon deletion of MYC were obtained from Seitz et al.
[29].
The binding events (peaks) for six circadian regulators (Bmal1, Clock, Cry1, Cry2, Per1,
Per2) and two RNA polymerase II states (8WG16 and ser5p) at six time points (1hr, 4hr, 8hr,
12hr, 16hr and 20hr) as well as the RPKM values of RNA sequencing data at the same time
points from murine liver samples were obtained from Koike et al. [28]. A total of 2629 genes had
both binding and RPKM data available for Per2. Differentially expressed genes upon deletion
of Per2 in murine liver [30] were obtained directly from the Gene Expression Omnibus using the
GEO2R tool (accession number GSE30139; 2409 genes with fold change >1.5 and FDR corrected
P -value<0.05).
From each source of data, we obtained a number of working sets of data where for each TF
there exists concordant data from binding, expression, and knockdown. For each TF and each
peak-to-gene model there were three datasets. The ChIP and expression data were matrices with
a row for each gene and a column for each condition, containing respectively the number of peaks
mapped to the TSS of that gene and its expression level. The knockdown data for ENCODE
was an expression change P -value for each gene and for mouse circadian was a list of genes with
significant expression change.
We also prepared ChIP data for the same factors with quantitative binding information (sum
of peak magnitudes for each gene). Finally we prepared alternative datasets filtered for CpG-rich
and CpG-depleted promoters, as obtained from the UCSC genome browser.
Prediction of functional TF target genes
The approach we took to predicting functional target genes looked at the correlation between
binding and expression profiles over a range of cell-types or conditions. However, we found that
correlation by any one method alone is a not necessarily a good predictor for any given factor or
binding model. We found that different correlation methods identify different types of relation
between binding and expression. To improve prediction we combined results from a number of
correlation methods in a wisdom of crowds approach.
For each dataset (i.e. for each TF and each peak-to-gene model) we computed the correla-
tion between the number of binding peaks and the expression of each gene across all conditions,
using three correlation measures: the absolute Pearson correlation coefficient (PC), the absolute
Spearman correlation coefficient (SC), and the absolute combined angle ratio statistic (CARS).
CARS is our variant of the angle ratio statistic (ARS) of Marstrand and Storey [25]. The ARS
was shown to have high power for detecting associations when both variables are restricted to a
narrow relative range, with one or very few cell types appearing as distinct outliers [25]. Whilst
ARS only considers positive associations between variables (i.e. where an increased number of
binding sites corresponds to increased expression of a target gene), CARS uses the same principle
to test for both positive and negative associations. We define CARS as follows. Vector ~x is a
vector of RNA-seq data and ~y is a vector of ChIP-seq data (for the same cell-types). Both vectors
have length t. Both vectors are then scaled: ~xs = ~xmax(|~x|) and likewise for ~y
s. Both vectors are
then median centred: ~x∗ = ~xs − med( ~xs) and likewise for ~y∗. Outlier distance is measured for
each point:
~d =
(√
x∗1
2 + y∗1
2, . . . ,
√
x∗t
2 + y∗t
2
)
(1)
and the ratio statistic
~r =
(
d1
med(~d)
, . . . ,
dt
med(~d)
)
(2)
quantifies the distance of each point from the medoid. We then take the angle of each point from
the x-axis ~θ = (θ1, . . . , θt) and form a positive angle statistic ~∆+ = (∆
+
1 , . . . ,∆
+
t ), the angular
3
distance of each point from the line x = y, and a negative angle statistic ~∆− = (∆−1 , . . . ,∆
−
t ), the
angular distance of each point from the line x = −y:
∆+i =
 |45− θi| 0 ≤ θi < 135|225− θi| 135 ≤ θi < 315|45− (θi − 360)| 315 ≤ θi < 360 , (3)
∆−i = 90−∆+i =
 |315− (θi + 360)| 0 ≤ θi < 45|135− θi| 45 ≤ θi < 225|315− θi| 225 ≤ θi < 360 . (4)
This is where CARS differs from ARS, which only measures angular distance from the line x = y.
The positive scores for each point are ARS+ = (ARS+1 , . . . ,ARS
+
t ) where ARS
+
i = ri× ec∆
+
i and
the negative scores ARS− are formed in the corresponding manner, with c < 0 a fixed parameter
of the method. The overall combined angle ratio statistic is then defined as
CARS =
 ARS
+
max ARS
+
max ≥ ARS−max
−ARS−max ARS+max < ARS−max
(5)
where ARS±max = max(ARS
±). The value of the parameter c was determined by requiring that
empirical P -values satisfied a correct null distribution (i.e. such that P -values > 0.5 had a uniform
distribution), following the procedure of Marstrand and Storey [25]. In this study we used c =
−0.01 which conformed to this requirement for all data sets.
For all three correlation measures, we kept track of whether the score originated from a positive
or negative association. For comparison purposes, we also considered the number of binding peaks
in the cell type where the knockdown experiment was performed (called “multiple binding”) as a
functional target predictor.
Measures of performance
We used the knockdown data as our gold standard for defining a functional effect of TF-binding
on target gene expression. We measured the predictive performance of each correlation method
and multiple binding by computing the precision vs. recall (PR) curves (where precision is the
proportion of predicted genes that are in the gold standard and recall is the proportion of the
gold standard set that was predicted) for each dataset. We then took, for each dataset, thresholds
on both the level of multiple binding and the correlation scores, and genes with scores above the
threshold were taken as positive predictions. To achieve comparable results between different TFs,
we chose thresholds to give a specific fold increase in precision over the background proportion
of bound genes with a knockdown effect (i.e., the proportion of genes bound in the knockdown
cell type that have a significant functional effect in the knockdown). We recorded the positively
identified genes and calculated the hypergeometric overlap P -value between the predicted gene
set and gold standard set. We chose to make comparisons at a 1.5-fold precision increase over the
background. In other words, if a fraction f of the reference gene set were differentially expressed
upon knockdown of a particular TF, we determined thresholds for the PC, SC and CARS such
that a fraction 1.5f of the genes exceeding the threshold were differentially expressed. For making
predictions for TFs for which no gold standard set was available, we chose the threshold to be the
top 1% of predictions.
Performance was measured on the intersection of genes with available knockdown differential
expression data (the reference gene set) and real correlation scores (i.e., non-constant binding
and expression profiles) or multiple-binding score (i.e., at least one peak in the knockdown cell
type for the current peak-to-gene model); in the CARS method, outliers in one dimension (e.g.
with constant binding profile) were penalized by the angular penalty but not excluded from the
calculation, as recommended by Marstrand and Storey [25] to ensure a correct null distribution.
For the biological validation of the predicted target sets, all genes in the complete set of 24,392
genes above the given score threshold were used, irrespective of the availability of knockdown data.
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Results
Number of binding sites in a gene locus is a weak predictor of functional
relevance of binding
In order to test the hypothesis that correlation between TF binding and gene expression across
cell types can be used as a predictor of the functional relevance of binding events, we used data
from the human ENCODE resource [2]. We selected eight TFs, each with ChIP-sequencing pro-
files in at least ten cell lines and corresponding RNA-sequencing data available for the same cell
lines. We first assigned genome-wide binding locations (peaks) to putative target genes if they
were within 5kb of the transcription start sites (TSSs) obtained from GENCODE V12. We then
defined the binding profile of a gene as the number of peaks associated to that gene across the
available cell types. We defined functional relevance of binding of a TF in a gene locus by whether
or not the gene is differentially expressed upon knockdown of the transcription factor. Although
a limited and stringent definition of functional relevance, this facilitated us to make a systematic
and quantitative comparison of different functional prediction methods. For five of the selected
TFs (EP300, EZH2, RAD21, TAF1 and YY1), siRNA knockdown data in a lymphoblastoid cell
line (GM12878) was available in the form of differential expression P -values for 8,872 genes [12].
The differentially expressed genes (P -value<0.05) were considered functional targets of the cor-
responding transcription factor (true positives) and the non-differentially expressed genes true
negatives. This resulted in five datasets (one for each TF) with binding profiles for 24,392 genes,
together with matching expression profiles for the same genes in the same cell types as well as
true positive and true negative functional target gene lists (see Methods for details).
We first calculated for each TF the ratio of functional targets among genes bound by the TF
in GM12878. These ratios showed only a very limited increase compared to the genome-wide
background ratio of functional targets, which was significant for only two factors (EP300 and
RAD21, hypergeometric P -value < 0.05, Supplementary Table 1). This result is consistent with
the finding by Cusanovich et al. [12] that only 12 of their 29 knockdowns with available ChIP-
sequencing data resulted in a significant overlap between binding and differential expression. We
then tried to improve results by predicting targets only if multiple binding sites are present.
For three factors (EP300, RAD21, and YY1), we could achieve a 1.5-fold increase in precision
(i.e., percentage of known functional targets) with hypergeometric P -value < 0.05. However, the
threshold number of binding sites had to be large and consequently the predicted target sets were
small (Supplementary Table 1).
Correlation across compendia of binding and expression profiles improves
functional target prediction
To investigate the utility of correlation-based methods to predict functional targets, we considered
three distinct association measures between binding and expression profiles across multiple cell
types: the absolute Pearson correlation coefficient (PC), which tests for a positive or negative
linear association (Figure 1a), the absolute Spearman correlation coefficient (SC), which tests for
a positive or negative monotonic trend (Figure 1b), and the combined angle ratio test statistic
(CARS), which tests for a non-linear “on-off” relationship in a positive or negative direction
(Figure 1c) (see Methods).
We validated the predictive performance of each method for each TF independently using
precision-recall (PR) curves. In all cases, high-scoring genes for any of the correlation measures
were more likely to be differentially expressed upon knockdown of the TF than low-scoring genes
(Figure 2). In particular, for four out of five factors (EP300, EZH2, RAD21, YY1) a small number
of targets were predicted with a precision close to one. This enrichment (high-precision-low-
recall region) translated into an improvement in the number of significant sets and the size of set
predicted compared to using multiple binding in the knockdown cell type. To enable comparison of
different methods across different factors, we determined for each method and each factor the score
threshold resulting in a 1.5-fold increase in precision compared to the genome-wide background
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Figure 1: Characteristic scatter plots of binding and expression profiles for known differentially
expressed targets, showing a linear relation favoured by Pearson correlation (a), a non-linear
monotonic relation favoured by Spearman correlation (b), and an outlier relation favoured by
CARS (c).
ratio of functional targets, and calculated the significance of the overlap between all functional
targets and targets predicted at this threshold using a hypergeometric test. We found significantly
enriched target sets for each factor for at least one, and often multiple, of the methods, predicting
significantly more target genes compared to using binding data from the knockdown cell type only
(MB) (Figure 3 and Supplementary Table 2).
Interestingly, taking the union of the predicted gene sets for each method gave a further increase
in overlap with the gold standard (Figure 3 and Supplementary Table 2). This was explained by
the fact that enriched target sets predicted by each method (PC, SC, and CARS) showed only a
limited overlap (Figure 4a), suggesting that all types of relations (linear, non-linear monotonic,
on-off; cf. Figure 1) do occur between binding and expression profiles of functional TF targets.
Since all three methods take into account both positive and negative associations between
binding and expression, we asked whether specific TFs show a bias for either sign. For four out
of five factors (EP300, RAD21, TAF1 and YY1), positive interactions dominated the predicted
target sets, suggesting that they mostly function as activators of expression. In contrast, for EZH2
most predicted interactions were negative (Figure 4b), consistent with the fact that more than
two thirds of the differentially expressed genes were up-regulated in response to EZH2 knockdown
[12]. EZH2 is indeed known to repress transcription by participating in histone mark H3K27me3
deposition as well as DNA methylation [31], although it also functions as a double-faceted molecule
in breast cancers, either as a transcriptional activator or repressor of NF-kB targets, depending
on the cellular context [32].
Cell-type specific studies have previously used quantitative TF binding information (i.e. peak
heights) to predict absolute expression levels [8, 9]. We therefore also tested our method using
ChIP-seq peak heights in place of counts. However we found no significant improvement in predic-
tion using quantitative information. Precision levels varied, but were similar to results obtained
via on-off binding (see Supplementary Figures 3,4 —compare with Figure 3). Cheng et al. [9]
also found that the cell-type specific expression of CpG-rich promoters was easier to predict than
CpG-depleted promoters. We therefore partitioned the gene set in the same way, and compared
results. Here too, the results showed that there is no significant difference on the precision overall
between CpG-rich and CpG-depleted genes (see Supplementary Figure 5), even after correcting
for the difference in the number of CpG-rich and CpG-depleted genes (see Supplementary Figure
6). However some improvement is shown for EZH2; this is not unreasonable, given that EZH2 is
known to target CpG-island promoters [33].
To understand the functional relevance of the predicted target sets, we performed gene ontology
enrichment analysis using BiNGO [34]. The target gene sets of each factor (Supplementary Data
1) were enriched for distinct and specific functional categories, such as “inflammatory response”
(EP300; P -value< 1.2×10−7), “generation of neurons” (EZH2; P -value< 1.6×10−12). In contrast,
the sets of genes bound a factor in the knockdown cell type (Supplementary Data 2) were enriched
for metabolic processes for all factors. Furthermore, of the 2,618 predicted functional target genes
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Figure 2: Precision vs. Recall curves for functional binding of EP300, EZH2, RAD21, TAF1 and
YY1 in the 5kbTSS peak to gene model predicted by each method, using 8,872 reference genes
(true positive and true negative functional targets). The top scale on the x-axis shows the number
of true positives for the corresponding recall value.
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(a) and size (b) for each method and TF at a predicted 1.5-fold precision over background.
This is compared to using binding data from the knockdown cell type only (MB). Significance
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Figure 4: Overlap of functional target sets for each factor predicted by each method at a predicted
1.5-fold precision over background (a). Number of positively and negatively correlated targets
predicted by each method for each factor at a predicted 1.5-fold precision over background (b).
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precision threshold determined by analysing the 8,872 reference genes.
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across all five TFs, 70% were predicted to be target of only one factor. In contrast, 82% of the
5,764 bound genes were bound by more than one TF. Taken together, these results suggest that
the correlation-based method is able to select smaller and more specific sets of functional target
genes from the hundreds to thousands of genes bound by a given factor in a given cell type.
Full target sets are available in Supplementary Datasets 59–93.
Correlation between binding and expression predicts functional targets
in non-ENCODE cell types
In the previous analyses, the gold standard validation data (differential expression results) were
obtained in a cell type that was also present as one of the ENCODE cell lines used to predict
targets. Next we asked whether correlation of binding and expression across a compendium of cell
types is also informative for predicting targets in cell types not present in the compendium.
Firstly, we predicted functional targets for three additional transcription factors (MYC, CEBPB
and REST) where binding and expression information was available in ten or more ENCODE cell
types, but not the perturbation data. These TFs typically bind to a few thousand gene loci in
any given cell type, but the correlation-based method enabled us to select only a few hundred
high-confidence functional targets by taking the union of top 1% predictions from each method.
The predicted targets of CCAAT/enhancer binding protein beta (CEBPB) were specifically en-
riched for the Wnt signalling pathway (P -value = 7.9× 10−4). CEBPB has a demonstrated role
in the suppression of Wnt/β-catenin signaling during adipogenesis [35]. CEBPB targets were
also enriched for the functional category “positive regulation of cytokine production during im-
mune response” (P -value = 9.1× 10−2), in line with the well characterised role of CEBPB in the
regulation of immune and inflammatory response genes [36]. Since the ENCODE cell types are
cancer-related rather than immunological or adipogenesis-related, this demonstrates the strength
of the correlation-based approach to find the most functionally relevant targets of a transcription
factor. Similarly, the predicted targets of REST were enriched for functions specific to neurons,
such as presynaptic membrane (P -value = 4.1 × 10−3). REST is identified as a key regulator
to protect neurons in parts of the brain from oxidative stress, as well as protein aggregations
characteristic of many neurodegenerative diseases [37].
Next, having confirmed that the correlation-based method is able to identify the most func-
tionally relevant targets, we investigated whether the high-confidence predicted targets are also
valid in other cell types. Reschen et al. [38] systematically investigated the role of CEBPB in
macrophage differentiation in an in vitro model for coronary artery disease. By performing ChIP
sequencing for CEBPB before and after macrophages differentiate into foam cells, they identified
5866 genes where CEBPB was bound at significantly higher levels in foam cells. Of these differen-
tially bound genes, 16% (935) were differentially expressed between foam cells and macrophages.
Of the 749 predicted CEBPB targets using our correlation-based method across ten ENCODE cell
lines, also 16% (119) of genes were differentially expressed between foam cells and macrophages.
Similarly, Seitz et al. [29] studied the role of MYC in Burkitt Lymphoma (BL) and identified 7054
MYC binding sites (6169 within 5kb of a TSS) in 5 BL cell lines. 530 (8.5%) of these bound
genes were differentially expressed after siRNA-mediated knock-downs of MYC in BL cell lines.
Our method predicted 728 MYC targets using the ENCODE data, which showed 9% overlap with
genes differentially expressed after siRNA-mediated knock-downs of MYC in BL cell lines. These
two analyses demonstrate that predictions derived using our approach have a precision that is
comparable to the ChIP sequencing performed in the exact cell line of interest. The recall on
the other hand is limited at this point due to the limited availability of cell types with matching
binding and expression data to build functional target predictions, and the possibility of missing
cell type specific targets.
Full target sets are available in Supplementary Datasets 3–58.
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Different binding target models work better for different TFs
To investigate whether assigning genome-wide binding locations (peaks) to putative target genes
using different peak-to-gene models results in improved performance, we considered seven peak-
to-gene models: 1kb, 5kb, 10kb or 50kb around the transcription start sites (TSSs) obtained
from GENCODE V12; 1kb or 5kb around the TSS and within the gene body; or the nearest
TSS. We then predicted the targets using the union of correlation methods for each of the gene
models. We noted that different peak-to-gene association models performed best for different
factors (Figure 5). Promoter proximal binding has previously been associated with the functional
relevance of binding [39]. Accordingly, for all five TFs, the 5kbTSS correlation gave significant
enrichment of functional targets (Figure 5). EZH2 and YY1 performed best when TSS proximal
peaks were considered. This suggests that EZH2 and YY1 are involved in transcriptional control
through promoter proximal elements only. To note, both EZH2 and YY1 predominantly bind in
promoter proximal regions [2]. Given that overall the 5kbTSS model performed better than the
1kbTSS model, this suggests the presence of alternate cell type specific promoters within 5kb of the
consensus annotated promoter. For EP300, the farther the peaks from the TSS were considered,
the better the predictions, such that the best results were obtained when all peaks were associated
to the nearest TSS (Figure 5). As the presence of EP300 is associated with active enhancers [40],
it is not surprising to find that the nearest TSS model works best for EP300. Similarly, the 10kb
peak-to-gene model was the best performer for RAD21.
Among the three correlation measures, CARS predicted the highest number of targets at the
1.5-fold precision threshold for most peak-to-gene models, with the exception of the nearest gene
model for EP300, where PC performed significantly better, indicating that linear interactions
dominate in this case (Supplementary Figures 1 and 2).
Correlation across time points of a defined biological process is also pre-
dictive of functional effects
We have demonstrated that correlation between binding patterns and expression values of genes
across multiple cell types can be used to predict functional targets. We then investigated whether
the correlation-based approach can be extended to other data types, such as time series. The
mammalian circadian clock is a cell-autonomous process with a period of about 24 hours. It
controls the sleep-wake cycle, blood pressure and hormone secretion by regulating key processes
such as metabolism, the cell cycle and DNA repair through feedback loops of transcriptional
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Figure 6: Precision vs. Recall curves for functional binding of PER2 in the 5kbTSS peak-to-gene
model by each method, using 21200 reference genes (true positive and true negative functional
targets).
regulators (Clock, Bmal1, Cry1, Cry2, Per1 and Per2) essential for the rhythmicity [41]. We
obtained genome-wide binding patterns (ChIP-sequencing data) for the six transcription factors
listed above, as well as gene expression profiles (RNA-sequencing data) at six time points (1, 4,
8, 12, 16 and 20 hours) in murine liver [28]. We predicted high confidence correlated genes by
considering the top 1% predictions of the union of correlations between binding and expression
across this time series, using the 5kbTSS promoter proximal peak-to-gene model. A gold standard
set of genes differentially expressed upon TF-perturbation in liver was available only for Per2 [30].
As before, the PR curve showed that targets predicted by correlation, but not multiple binding,
were enriched for known functional targets (Figure 6).
The high-confidence predicted Per2 targets were highly expressed at 16 and 20 hours, similar
to the gene expression pattern of Per2 itself, and were more likely to be bound by Cry1/Cry2
than Clock/Bmal1 [28]. They were enriched for the functional category “regulation of RNA
metabolic process” (P -value = 4.3 × 10−3). Although 10% of the liver transcriptome follows a
circadian rhythm, only about half of it can be explained by de novo transcription, suggesting that
mRNA processing may play a key role in the circadian rhythmicity. Per2 is associated with RNA
processing through the RNA-dependent methylation process [42]. This again demonstrates that
the correlation-based approach enables the identification of a small set of highly-relevant functional
targets among the tens of thousands of genes bound by a given transcription factor.
Discussion
In this study, we have applied the guilt-by-association principle to predict functional targets of
transcription-associated factors by testing if a gene’s TF-specific binding profile across multiple
cell types correlated (positively or negatively) with its expression profile across the same cell types,
using three distinct correlation measures (Pearson and Spearman correlation and the combined
angle ratio statistic) and a range of cumulative regulatory models for mapping TF-binding peaks
to transcription start sites. Compared to the traditional approach where target genes are inferred
from the presence of one or more binding sites in a gene locus in a cell type of interest, the three
correlation-based methods showed improved prediction of functional targets, defined here as genes
differentially expressed upon TF knockdown, especially when used in combination.
It is known that TFs function in a condition-specific manner, and it may not be obvious
that correlation-based measures across multiple cell types are able to identify functional targets.
However, it is precisely the presence of binding and associated change in a target gene’s expression
level in the cell type(s) where the TF is active, and the absence of this signal in other cell types,
which leads to a high-confidence prediction. The angle ratio statistic was developed precisely to
detect such cell-type specific effects with high specificity [25], and was indeed found to predict a
significantly higher number of functional targets at the same enrichment threshold compared to
the Pearson and Spearman correlation, which predominantly select linear or monotonic trends,
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respectively. Furthermore, if binding of a factor varies across a compendium of cell types, then the
correlation between binding and expression was found to be predictive of functional effects even
in cell types that were not part of the compendium. Although more work is needed to investigate
the condition-specific properties of predicted functional target genes, our results suggest that
correlation-based predictions capture both condition-specific and condition-independent targets of
a TF.
Interestingly, these results were confirmed using a time course of matching binding and ex-
pression data in a single cell type, showing the wide validity of the guilt-by-association principle
for functional TF-binding prediction. In contrast to the ENCODE results, only the Pearson and
Spearman correlation predicted significantly enriched target sets in this case, whereas the CARS
outlier detection method did not perform well. This is consistent with the fact that samples from
the same tissue at different time points are more similar to each other than samples from highly
distinct cell types, and emphasizes the importance of combining different correlation methods to
detect all types of signal present in a dataset.
Four limitations affect the current study and need to be taken into account. Firstly, our defini-
tion of a gold standard of true positive and true negative functional target genes from differential
expression data following knockdown of a TF is only a proxy for true functional binding events,
namely when the binding of a TF in a gene locus significantly affects the gene’s rate of transcrip-
tion. However no large-scale data of changes in transcription rates following TF knockdowns is
currently available. Secondly, although the human ENCODE ChIP-seq matrix currently reports
data for nearly 200 TFs and more than 80 cell types, it is very sparse. Indeed, only eight TFs had
ChIP-seq profiles available in more than ten cell types with matching RNA-seq data, which we
considered a minimum to perform a correlation-based analysis. Of the eight factors considered,
half were sequence-specific TFs (CEBPB, MYC, REST and YY1) and half were general factors:
two promoter-associated (EZH2 and TAF1), one enhancer-associated (EP300) and one involved
in three-dimensional DNA organization (RAD21). Of the sequence-specific TFs, only one (YY1)
had knock-out data available in the lymphoblastoid cell line and could thus be validated directly.
As more data will become available, it will be important to establish if the reported results also
hold for a wider range of sequence-specific transcription factors. Thirdly, predicting the effect of
a particular TF on a particular gene naturally depends on the reliability of the ChIP-seq experi-
ments for that TF, but even within the ENCODE resource, with its high standards for technical
quality control, the biological quality of samples is not always guaranteed [43]. Lastly, we only
considered the presence of binding sites and expression data to investigate the improvement in
functional prediction by correlation-based methods compared to using the presence of binding sites
only. Although we found that taking into account binding peak height or promoter CpG content
did not improve our predictions, we did not consider the presence of sequence motifs or various
chromatin features. These have been shown to improve prediction of cell-type specific variation
in expression among genes [8, 9], and will likely also improve prediction of functional targets.
Having established the validity of the correlation-based method, future work will be aimed at
building functional target gene predictors that combine this approach with additional data types
and existing knowledge. Despite these limitations, we believe that the use of correlated features in
compendia of binding and expression profiles with matching conditions is a powerful novel method
to predict functional TF target genes, which is able to identify high-confidence functional target
genes among the thousands of genes bound by a given transcription factor.
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Figure S1: Functional target set significance (hypergeometric P-value) predicted by each of the
correlation methods for all peak-to-gene models at a predicted 1.5-fold precision over background.
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Figure S2: Functional target set sizes predicted by each of the correlation methods for all peak-
to-gene models at a predicted 1.5-fold precision over background. Set sizes refer to subsets of the
complete set of 24,392 genes exceeding the 1.5-fold precision threshold determined by analysing
the 8,872 reference genes.
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Figure S3: Functional target set significance (hypergeometric P-value) using quantitative (sum
of peak heights) ChIP-seq data predicted by each of the correlation methods for the prom5kb
peak-to-gene model at a predicted 1.5-fold precision over background.
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Figure S4: Functional target set significance (hypergeometric P-value) using quantitative (sum
of peak heights) ChIP-seq data predicted by each of the correlation methods for all peak-to-gene
models at a predicted 1.5-fold precision over background.
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Figure S5: Functional target set significance (hypergeometric P-value), using CpG partitioned
datasets, predicted by each of the correlation methods for all peak-to-gene models at a predicted
1.5-fold precision over background. We show significance using all genes (blue), only CpG-rich
promoters (green), and only CpG-depleted promoters (red).
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Figure S6: Functional target set significance (hypergeometric P-value), using CpG partitioned
datasets, each of 1000 randomly selected genes, predicted by each of the correlation methods for
all peak-to-gene models at a predicted 1.5-fold precision over background. We show significance
using all genes (blue), only CpG-rich promoters (green), and only CpG-depleted promoters (red).
All results are the average of 100 random samples of 1000 genes per set.
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Binding MB
TF Model Background Bound p n p
EP300 geneprom1000 0.385 0.424 0.000858 0 1
geneprom5000 0.385 0.425 0.00048 0 1
prom1000 0.385 0.394 0.347 0 1
prom5000 0.385 0.413 0.0512 0 1
prom10kb 0.385 0.426 0.00679 23 0.0243
prom50kb 0.385 0.445 2.97e-06 86 0.000156
nearestgene 0.385 0.447 1.03e-07 29 0.0218
EZH2 geneprom1000 0.216 0.186 0.923 0 1
geneprom5000 0.216 0.197 0.827 0 1
prom1000 0.216 0.178 0.877 0 1
prom5000 0.216 0.216 0.529 0 1
prom10kb 0.216 0.21 0.607 0 1
prom50kb 0.216 0.212 0.59 0 1
nearestgene 0.216 0.205 0.72 0 1
RAD21 geneprom1000 0.38 0.398 0.000132 18 0.0392
geneprom5000 0.38 0.4 5.55e-06 19 0.0618
prom1000 0.38 0.391 0.173 6 0.152
prom5000 0.38 0.415 3.7e-06 12 0.125
prom10kb 0.38 0.423 6.05e-10 47 0.00509
prom50kb 0.38 0.405 3.08e-08 0 1
nearestgene 0.38 0.402 9.34e-08 1 0.38
TAF1 geneprom1000 0.236 0.229 0.995 4 0.239
geneprom5000 0.236 0.229 0.995 4 0.239
prom1000 0.236 0.23 0.938 0 1
prom5000 0.236 0.231 0.947 13 0.173
prom10kb 0.236 0.229 0.977 0 1
prom50kb 0.236 0.23 0.953 4 0.239
nearestgene 0.236 0.232 0.924 4 0.239
YY1 geneprom1000 0.311 0.308 0.835 0 1
geneprom5000 0.311 0.307 0.893 0 1
prom1000 0.311 0.305 0.919 0 1
prom5000 0.311 0.309 0.712 5 0.0349
prom10kb 0.311 0.31 0.57 14 0.109
prom50kb 0.311 0.308 0.756 3 0.229
nearestgene 0.311 0.308 0.791 4 0.367
Table S1: Overlap between various predicted and known functional TF-target sets for ENCODE
data. Binding: the ratio of differentially expressed genes among all 8,872 reference genes (Back-
ground) and among genes bound by the TF in the given peak-to-gene model (Bound), and the
hypergeometric overlap P -value (p). Multiple Bind: gene sets predicted by a threshold on the
number of peaks with a 1.5-fold increase in ratio of differentially expressed genes compared to the
background, showing the number of genes (n) and hypergeometric overlap P -value (p). All subset
sizes refer to the number of 8,872 reference genes exceeding the threshold. Significant P -values
(< 0.05) are indicated in bold
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PC SC CARS Union
TF Model n p n p n p n p
EP300 geneprom1000 41 0.00709 0 1 29 0.0218 63 0.00084
geneprom5000 43 0.00681 0 1 43 0.00681 78 0.000418
prom1000 25 0.0236 17 0.0715 25 0.0236 58 0.000575
prom5000 12 0.132 12 0.132 51 0.00246 69 0.000754
prom10kb 45 0.00653 25 0.0236 43 0.00681 93 9.07e-05
prom50kb 24 0.0381 8 0.151 31 0.0209 59 0.00211
nearestgene 119 1.07e-05 0 1 32 0.0131 138 1.08e-05
EZH2 geneprom1000 6 0.383 3 0.518 92 0.00889 94 0.0123
geneprom5000 6 0.383 6 0.383 46 0.0546 52 0.0415
prom1000 3 0.518 0 1 46 0.0546 47 0.0648
prom5000 9 0.304 9 0.304 61 0.0277 71 0.0221
prom10kb 3 0.518 3 0.518 9 0.304 14 0.166
prom50kb 0 1 6 0.383 0 1 6 0.383
nearestgene 3 0.518 5 0.295 9 0.304 14 0.166
RAD21 geneprom1000 35 0.0162 3 0.323 61 0.00156 91 0.000145
geneprom5000 0 1 6 0.152 70 0.000826 76 0.000311
prom1000 26 0.0322 31 0.0181 47 0.00509 92 0.00046
prom5000 21 0.058 56 0.00267 45 0.00534 108 0.000138
prom10kb 28 0.0304 34 0.0107 71 0.000532 116 1.03e-05
prom50kb 35 0.0162 54 0.00281 8 0.144 86 0.000544
nearestgene 0 1 22 0.0358 14 0.115 36 0.0103
TAF1 geneprom1000 8 0.288 0 1 14 0.219 17 0.194
geneprom5000 8 0.288 0 1 19 0.139 22 0.126
prom1000 50 0.0328 18 0.0133 11 0.25 67 0.00809
prom5000 47 0.0358 32 0.0552 70 0.0149 130 0.0028
prom10kb 0 1 36 0.0293 64 0.0176 100 0.00173
prom50kb 2 0.417 28 0.103 59 0.0253 87 0.00748
nearestgene 5 0.338 50 0.0328 62 0.0232 112 0.00247
YY1 geneprom1000 10 0.169 0 1 6 0.275 16 0.0886
geneprom5000 10 0.169 0 1 12 0.135 22 0.0489
prom1000 47 0.0166 9 0.112 4 0.367 53 0.00983
prom5000 8 0.213 17 0.123 8 0.213 29 0.0386
prom10kb 0 1 0 1 25 0.0563 25 0.0563
prom50kb 0 1 0 1 12 0.135 12 0.135
nearestgene 4 0.367 7 0.14 10 0.169 20 0.0594
Table S2: Overlap between various predicted and known functional TF-target sets for ENCODE
data. Pearson Correlation (PC), Spearman Correlation (SC), Combined Angle Ratio Statistic
(CARS), and Union: gene sets predicted by a threshold on the correlation score, for each method
respectively and for the union of those sets, with a 1.5-fold increase in ratio of differentially
expressed genes compared to the background, showing the number of genes (n) and hypergeometric
overlap P -value (p). All subset sizes refer to the number of 8,872 reference genes exceeding the
threshold. Significant P -values (< 0.05) are indicated in bold
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Binding MB
TF Model Background Bound p n p
Per2 geneprom1kb 0.281 0.281 0.486 1 0.281
geneprom5kb 0.281 0.282 0.266 11 0.17
prom1kb 0.268 0.269 0.397 0 1
prom5kb 0.272 0.277 0.0414 0 1
prom10kb 0.28 0.284 0.0535 30 0.0217
prom50kb 0.279 0.281 0.141 21 0.102
nearestgene 0.278 0.28 0.101 2 0.478
Cry1 geneprom1kb 0.0126 0.0126 0.734 939 0.0196
geneprom5kb 0.0129 0.0129 0.726 580 0.0652
prom1kb 0.0109 0.0108 0.796 70 0.0393
prom5kb 0.0123 0.0124 0.644 365 0.0752
prom10kb 0.0124 0.0125 0.562 234 0.068
prom50kb 0.0127 0.0128 0.439 213 0.132
nearestgene 0.0127 0.0127 0.7 916 0.035
Cry2 geneprom1kb 0.014 0.0136 0.897 1040 0.0177
geneprom5kb 0.014 0.0136 0.896 185 0.257
prom1kb 0.0128 0.0121 0.903 171 0.171
prom5kb 0.013 0.0125 0.89 106 0.157
prom10kb 0.014 0.0134 0.932 24 0.287
prom50kb 0.0149 0.0146 0.858 103 0.198
nearestgene 0.0148 0.0147 0.701 378 0.103
Table S3: Overlap between various predicted and known functional TF-target sets for mouse
circadian data. Binding: the ratio of differentially expressed genes among all 8,872 reference genes
(Background) and among genes bound by the TF in the given peak-to-gene model (Bound), and
the hypergeometric overlap P -value (p). Multiple Bind: gene sets predicted by a threshold on the
number of peaks with a 1.5-fold increase in ratio of differentially expressed genes compared to the
background, showing the number of genes (n) and hypergeometric overlap P -value (p). Significant
P -values (< 0.05) are indicated in bold
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PC SC CARS Union
TF Model n p n p n p n p
Per2 geneprom1kb 2 0.483 10 0.119 0 1 10 0.119
geneprom5kb 0 1 10 0.119 0 1 10 0.119
prom1kb 4 0.292 2 0.464 0 1 6 0.198
prom5kb 17 0.153 3 0.182 0 1 19 0.117
prom10kb 0 1 9 0.225 0 1 9 0.225
prom50kb 0 1 0 1 0 1 0 1
nearestgene 0 1 0 1 0 1 0 1
Cry1 geneprom1kb 2164 0.00039 1728 0.000496 528 0.124 2432 0.000524
geneprom5kb 1807 0.00239 1807 0.00239 619 0.0959 2288 0.000677
prom1kb 856 0.0549 61 0.491 367 0.203 1015 0.0509
prom5kb 1026 0.0301 702 0.0778 486 0.137 1298 0.0117
prom10kb 268 0.238 45 0.107 536 0.121 691 0.138
prom50kb 420 0.16 1204 0.0207 473 0.142 1493 0.012
nearestgene 787 0.0671 1393 0.0101 577 0.111 1760 0.00607
Cry2 geneprom1kb 1570 0.00144 566 0.087 54 0.536 1609 0.00238
geneprom5kb 1670 0.00103 608 0.0356 95 0.385 1727 0.000851
prom1kb 622 0.0659 229 0.162 0 1 622 0.0659
prom5kb 974 0.0201 422 0.0368 512 0.111 1144 0.00134
prom10kb 1145 0.0095 427 0.0287 572 0.0873 1339 0.00123
prom50kb 44 0.485 0 1 760 0.0484 773 0.0555
nearestgene 1352 0.00667 774 0.0289 135 0.322 1468 0.00298
Table S4: Overlap between various predicted and known functional TF-target sets for mouse
circadian data. Pearson Correlation (PC), Spearman Correlation (SC), Combined Angle Ratio
Statistic (CARS), and Union: gene sets predicted by a threshold on the correlation score, for each
method respectively and for the union of those sets, with a 1.5-fold increase in ratio of differentially
expressed genes compared to the background, showing the number of genes (n) and hypergeometric
overlap P -value (p). Significant P -values (< 0.05) are indicated in bold
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Data TFs Source
Human
ChIP-seq EP300
EZH2
RAD21
TAF1 https://genome.ucsc.edu/ENCODE/dataMatrix/encodeChipMatrixHuman.html
YY1
CEBPB
MYC
REST
RNA-seq EP300
EZH2
RAD21
TAF1 https://genome.ucsc.edu/ENCODE/dataMatrix/encodeDataMatrixHuman.html
YY1
CEBPB
MYC
REST
Knockout EP300
EZH2
RAD21 Cusanovich et al. (2014)
TAF1
YY1
Mouse
ChIP-seq Bmal1
& Clock
RNA-seq Cry1 Koike et al. (2012)
Cry2
Per1
Per2
Knockout Per2 http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE30139
Table S5: Data sources.
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